Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer symbols : A save search
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -0.28%
H: 0.75%
C: -0.03%
cancer research diagnostics
Clinical Biomarkers Market Analysis and Forecast, 2023-2033 - Cancer Biomarkers to Witness the Highest Growth between 2023 and 2033
Published: 2024-02-13 (Crawled : 03:00) - prnewswire.com
TMO | News | $544.01 0.46% 470K
|
Health Technology
|
| O: -0.99%
H: 0.88%
C: -0.52%
DGX | $128.08 1.72% 770K
|
Health Services
|
| O: 0.01%
H: 0.55%
C: -1.66%
QGEN | $40.025 1.41% 560K
|
Health Technology
|
| O: -1.64%
H: 0.58%
C: -0.56%
BIO | News | $277.33 -1.31% 110K
|
Health Technology
|
| O: -1.32%
H: 0.37%
C: -1.83%
BDX | $234.09 0.4% 620K
|
Health Technology
|
| O: 0.04%
H: 0.72%
C: -1.81%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -2.03%
H: 1.0%
C: -0.44%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.94%
H: 0.0%
C: 0.0%
QGEN | $40.03 1.42% 500K
|
Health Technology
|
| O: -1.64%
H: 0.58%
C: -0.56%
MYGN F | $18.3 -1.14% 200K
|
Health Technology
|
| O: -3.99%
H: 1.49%
C: -3.71%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: -2.48%
H: 1.08%
C: -2.01%
CNTG | $0.461 58K
|
Commercial Services
|
| O: 2.59%
H: 0.0%
C: -11.11%
cancer biomarkers growth market
Gastric Cancer Diagnostic Market to Reach $3.8 Billion, Globally, by 2032 at 5.3% CAGR: Allied Market Research
Published: 2023-11-10 (Crawled : 15:30) - prnewswire.com
BIO | News | $277.33 -1.31% 110K
|
Health Technology
|
| O: -0.27%
H: 0.44%
C: -0.63%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
EXAS | $60.79 -4.24% 1.1M
|
Health Technology
|
| O: -0.23%
H: 1.53%
C: 0.44%
diagnostic reach cancer research market
Global Biopsy Devices Market Projected to Reach $11.86 Billion by 2027, Fueled by Rising Cancer Incidence and Advanced Diagnostic Procedures
Published: 2023-11-10 (Crawled : 01:00) - prnewswire.com
TMO | News | $544.01 0.46% 470K
|
Health Technology
|
| O: -3.09%
H: 0.0%
C: 0.0%
SYK | $326.26 -0.36% 770K
|
Health Technology
|
| O: 0.3%
H: 1.31%
C: 0.72%
MDT | $79.255 0.08% 2.6M
|
Health Technology
|
| O: 0.49%
H: 0.57%
C: 0.35%
CNMD | $72.34 1.77% 140K
|
Health Technology
|
| O: 0.21%
H: 1.91%
C: 1.65%
CAH | $107.26 1.19% 290K
|
Distribution Services
|
| O: 0.26%
H: 1.46%
C: 1.01%
BSX | $67.235 -0.27% 3.7M
|
Health Technology
|
| O: 0.43%
H: 0.41%
C: -0.17%
BIO | News | $277.33 -1.31% 110K
|
Health Technology
|
| O: -0.27%
H: 0.44%
C: -0.63%
BDX | $234.09 0.4% 620K
|
Health Technology
|
| O: 0.68%
H: 0.8%
C: 0.35%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: -12.11%
H: 4.83%
C: 4.63%
CNMD | $72.39 1.84% 180K
|
Health Technology
|
| O: 0.21%
H: 1.91%
C: 1.65%
diagnostic reach cancer global market
Pancreatic Cancer Diagnostics Market: Growing Prevalence of Pancreatic Cancer Drives Demand for Innovative Diagnostic Tools
Published: 2023-10-27 (Crawled : 16:00) - prnewswire.com
TMO | News | $544.01 0.46% 470K
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: 0.0%
LH M | $200.35 0.45% 250K
|
Health Services
|
| O: -0.5%
H: 0.69%
C: -2.89%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 0.22%
H: 0.23%
C: -1.69%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 1.57%
H: 0.6%
C: -2.01%
diagnostic cancer pancreatic tools growing diagnostics
Global Pancreatic Cancer Diagnostic Market Set to Reach USD 3.90 Billion by 2030 with a CAGR of 6.53%
Published: 2023-10-17 (Crawled : 00:00) - prnewswire.com
PHG | $20.0 0.1% 340K
|
Health Technology
|
| O: -2.21%
H: 0.7%
C: -0.32%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MYGN F | $18.3 -1.14% 200K
|
Health Technology
|
| O: -1.01%
H: 2.44%
C: 2.03%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: -1.46%
H: 0.11%
C: -4.23%
diagnostic reach cancer pancreatic global set market
Global Next Generation Cancer Diagnostics Market Research Report 2023-2030: Key Players are Focusing on Innovative Product Launches and Geographical Expansion to Maintain their Competitive Edge
Published: 2023-10-06 (Crawled : 09:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: -0.52%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.95%
H: 0.41%
C: 0.08%
PHG | $20.0 0.1% 340K
|
Health Technology
|
| O: -9.44%
H: 2.86%
C: 2.46%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -1.81%
H: 2.08%
C: 1.05%
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -1.32%
H: 2.68%
C: 2.01%
MYGN F | $18.3 -1.14% 200K
|
Health Technology
|
| O: -0.97%
H: 4.4%
C: -0.59%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: -1.36%
H: 2.95%
C: 1.8%
report cancer expansion research global diagnostics market
Agilent Showcases Comprehensive Cancer Portfolio Solutions at AACR 2023
Published: 2023-04-14 (Crawled : 13:00) - biospace.com/
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -0.65%
H: 0.59%
C: -0.83%
cancer solutions
United States Prostate Cancer Testing Market Report 2022: A $544 Million Market by 2030 - Increasing Number of Prostate Cancer Screening and Testing
Published: 2023-02-28 (Crawled : 11:00) - prnewswire.com
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -0.3%
H: 1.15%
C: 0.16%
VCYT | $19.1 -0.52% 230K
|
Health Technology
|
| O: -0.33%
H: 4.68%
C: 1.95%
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 0.88%
H: 1.75%
C: 0.0%
MYGN F | $18.3 -1.14% 200K
|
Health Technology
|
| O: -0.59%
H: 4.95%
C: 1.83%
EXAS | $60.79 -4.24% 1.1M
|
Health Technology
|
| O: -0.38%
H: 4.78%
C: 3.92%
ABCM | $23.99 0.0% 7.4M
|
Health Technology
|
| O: -0.7%
H: 1.61%
C: 1.05%
report cancer market
Global Prostate Cancer Testing Market Research Report 2022: The Focus of Business Leaders is Establishing a Deep Understanding to Address the Unmet Needs in Clinical Research
Published: 2023-02-08 (Crawled : 17:00) - prnewswire.com
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -0.56%
H: 1.0%
C: 0.51%
VCYT | $19.1 -0.52% 230K
|
Health Technology
|
| O: -1.3%
H: 2.97%
C: 0.08%
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -5.19%
MYGN F | $18.3 -1.14% 200K
|
Health Technology
|
| O: -0.82%
H: 3.81%
C: -2.93%
EXAS | $60.79 -4.24% 1.1M
|
Health Technology
|
| O: -0.53%
H: 2.18%
C: -0.57%
ABCM | $23.99 0.0% 7.4M
|
Health Technology
|
| O: -0.64%
H: 2.25%
C: -2.76%
research global report cancer market prostate cancer
Pancreatic Cancer Diagnostics Market is Likely to Upsurge at a CAGR of 7.5% by 2030, Size, Share, Trends, Demand, Growth, Opportunities and Competitors Analysis
Published: 2023-01-24 (Crawled : 21:00) - prnewswire.com
LH M | $200.35 0.45% 250K
|
Health Services
|
| O: -0.58%
H: 0.85%
C: 0.47%
PHG | $20.0 0.1% 340K
|
Health Technology
|
| O: -0.89%
H: 0.75%
C: 0.12%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -1.09%
H: 1.65%
C: 1.14%
MYGN F | $18.3 -1.14% 200K
|
Health Technology
|
| O: -1.0%
H: 0.1%
C: -1.2%
diagnostics cancer market pancreatic
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
Published: 2023-01-04 (Crawled : 15:00) - biospace.com/
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 1.07%
H: 0.92%
C: 0.01%
acquisition research cancer
Hereditary Cancer Testing Market to Reach USD 10.1 Billion, Globally, by 2031 at 11.6% CAGR, Says Allied Market Research
Published: 2022-10-14 (Crawled : 16:00) - prnewswire.com
QGEN | $40.025 1.41% 560K
|
Health Technology
|
| O: 1.42%
H: 1.15%
C: -1.73%
DHR | $235.0 -0.58% 1.1M
|
Health Technology
|
| O: 0.65%
H: 0.71%
C: -2.02%
BIO | News | $277.33 -1.31% 110K
|
Health Technology
|
| O: 0.59%
H: 0.99%
C: -0.63%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 0.86%
H: 0.95%
C: -2.56%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.69%
H: 0.72%
C: -2.2%
QGEN | $40.03 1.42% 500K
|
Health Technology
|
| O: 1.42%
H: 1.15%
C: -1.73%
MYGN F | $18.3 -1.14% 200K
|
Health Technology
|
| O: 1.2%
H: 0.41%
C: -3.76%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: 0.88%
H: 0.8%
C: -2.5%
research cancer market
Next Generation Cancer Diagnostics Market Augmented to Reach USD 31.75 Billion with a CAGR of 18.1% | Analysed by Key Insights, Regional Analysis with Future Outlook by 2028
Published: 2022-07-15 (Crawled : 06:00) - prnewswire.com
GE | $149.17 -2.47% 6.2M
|
Electronic Technology
|
| O: 1.89%
H: 1.46%
C: 1.26%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 0.31%
H: 0.93%
C: 0.89%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: 1.94%
H: 5.39%
C: 4.73%
diagnostics cancer market
Global $3.25+ Billion Lung Cancer Genomic Testing Markets to 2031: Focus on Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
DGX | $128.08 1.72% 770K
|
Health Services
|
| O: 0.43%
H: 2.47%
C: 1.85%
QGEN | $40.025 1.41% 560K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
LH M | $200.35 0.45% 250K
|
Health Services
|
| O: 2.35%
H: 2.94%
C: 2.21%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 0.4%
H: 13.31%
C: 13.31%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 1.38%
H: 3.62%
C: 3.49%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 2.4%
H: 0.0%
C: 0.0%
VCYT | $19.1 -0.52% 230K
|
Health Technology
|
| O: 0.75%
H: 15.68%
C: 15.57%
QGEN | $40.03 1.42% 500K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 5.62%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: 0.0%
CNTG | $0.461 58K
|
Commercial Services
|
| O: -4.76%
H: 34.5%
C: 3.0%
genomic cancer
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
Published: 2022-05-10 (Crawled : 23:00) - biospace.com/
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 2.06%
H: 2.17%
C: 1.04%
europe diagnostic cancer
Next-Generation Gynecological Cancer Diagnostics Market, 2031
Published: 2022-04-27 (Crawled : 10:00) - prnewswire.com
TMO | News | $544.01 0.46% 470K
|
Health Technology
|
| O: -2.87%
H: 0.0%
C: 0.0%
DGX | $128.08 1.72% 770K
|
Health Services
|
| O: -0.43%
H: 3.45%
C: 1.79%
QGEN | $40.025 1.41% 560K
|
Health Technology
|
| O: 0.91%
H: 1.37%
C: 0.09%
LH M | $200.35 0.45% 250K
|
Health Services
|
| O: -3.91%
H: 2.25%
C: 1.17%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -6.95%
H: 4.32%
C: -1.38%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -2.2%
H: 2.24%
C: -0.44%
QGEN | $40.03 1.42% 500K
|
Health Technology
|
| O: 0.91%
H: 1.37%
C: 0.09%
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -6.64%
H: 1.78%
C: -1.42%
MYGN F | $18.3 -1.14% 200K
|
Health Technology
|
| O: -2.62%
H: 3.04%
C: 0.09%
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: -3.78%
H: 2.05%
C: -1.05%
FLGT | $20.125 0.08% 49K
|
Health Services
|
| O: -3.5%
H: 3.75%
C: 0.29%
CNTG | $0.461 58K
|
Commercial Services
|
| O: -2.84%
H: 1.46%
C: -1.17%
diagnostics cancer diagnostic
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
Published: 2022-04-08 (Crawled : 13:00) - biospace.com/
A | $132.86 0.32% 620K
|
Health Technology
|
| O: -0.16%
H: 0.94%
C: -0.62%
research solutions genomics cancer
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
Published: 2021-10-28 (Crawled : 22:00) - biospace.com/
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 0.46%
H: 1.16%
C: -0.14%
europe cancer breast cancer diagnostic
Quest Diagnostics to Introduce Ki-67 IHC MIB-1 pharmDx, the First Companion Diagnostic for Eli Lilly and Company's Verzenio® (abemaciclib), a CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Published: 2021-10-18 (Crawled : 18:00) - biospace.com/
DGX | $128.08 1.72% 770K
|
Health Services
|
| O: -0.18%
H: 1.13%
C: 1.04%
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: 0.14%
H: 1.98%
C: 0.43%
A | $132.86 0.32% 620K
|
Health Technology
|
| O: 0.23%
H: 1.17%
C: 0.75%
ema risk cancer breast cancer diagnostics her2+ diagnostic her2- her2
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.